Chondroitin sulfate-based anti-inflammatory macromolecular prodrugs

European Journal of Pharmaceutical Sciences

Volumn 29, Issue 1, 2006, Pages 60-69

  Peng, Yu Shiang ^a   Lin, Shih Chun ^a   Huang, Shih Jer ^a   Wang, Yu Ming ^a   Lin, Ying Jer ^a   Wang, Li Fang ^a   Chen, Jenn Shing ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL UNIVERSITY OF KAOHSIUNG   (Taiwan)

Author keywords

Chondroitin sulfate; Ibuprofen; Ketoprofen; Macromolecular prodrug; Naproxen; Non steroidal anti inflammatory drug

Indexed keywords

BUFFER; CARRAGEENAN; CHONDROITIN SULFATE; DIMETHYL SULFOXIDE; ESTERASE; IBUPROFEN; IMIDAZOLE DERIVATIVE; IMIDE; KETOPROFEN; MACROGOL 1000; MACROGOL DERIVATIVE; N ACETYLGALACTOSAMINE 4 SULFATASE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DILUTION; DRUG CONJUGATION; DRUG RELEASE; DRUG SYNTHESIS; EDEMA; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MACROMOLECULE; MALE; NONHUMAN; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; CARRAGEENAN; CHEMISTRY, PHYSICAL; CHONDROITIN ABC LYASE; CHONDROITIN SULFATES; EDEMA; EXCIPIENTS; HYDROLYSIS; IBUPROFEN; KETOPROFEN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NAPROXEN; POLYETHYLENE GLYCOLS; PRODRUGS; RATS; RATS, WISTAR; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 33747760391     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.05.010     Document Type: Article

References (24)

1. Bonina F., Puglia C., Santagati N.A., Saija A., Tomaino A., and Tita B. Oligoethylene ester derivatives of ketoprofen, naproxen and diclofenac as oral prodrugs: a pharmacological evaluation. Pharmazie 57 (2002) 552-555
2. Bonina F.P., Puglia C., Barbuzzi T., Caprariis P., Palagiano F., Rimoli M.G., and Saija A. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. Eur. J. Pharm. Sci. 14 (2001) 123-134
3. Bourgeois P., Chales G., Dehais J., Delcambre B., Kuntz J.L., and Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs. chondroitin sulfate 3 × 400 mg/day vs. placebo. Osteoarthritis Cartilage 6 Suppl. A (1998) 25-30
4. Cheng H., Cao X., Xian M., Fang L., Cai T.B., Ji J.J., Tunac J.B., Sun D., and Wang P.G. Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity. J. Med. Chem. 48 (2005) 645-652
5. Conforti A., Caliceti P., Sartore L., Schiavon O., Veronese F., and Velo G.P. Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats. Pharmacol. Res. 23 (1991) 51-56
6. Greenwald R.B., Choe Y.H., McGuire J., and Conover C.D. Effective drug delivery by PEGylated drug conjugates. Adv. Drug Deliv. Rev. 55 (2003) 217-250
7. Harboe E., Larsen C., Johansen M., and Olesen H.P. Macromolecular prodrugs. XV. Colon-targeted delivery-bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig. Pharm. Res. 6 (1989) 919-923
8. Heyneman C.A., Lawless-Liday C., and Wall G.C. Oral versus topical NSAIDs in rheumatic disease: a comparison. Drugs 60 (2000) 555-574
9. Kamada M., Hirayama F., Udo K., Yano H., Arima H., and Uekama K. Cyclodextrin conjugate-based controlled release system: repeated- and prolonged-release of ketoprofen after oral administration in rats. J. Control. Release 82 (2002) 407-416
10. Kyuki K. Evaluation of non-steroidal anti-inflammatory drugs (NSAID) intended for use as topical anti-inflammatory drugs. Nippon Yakurigaku Zasshi 79 (1982) 461-485
11. Larsen C., Jensen B.H., and Olesen H.P. Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig. Acta. Pharm. Nordica 3 (1991) 71-76
12. Lombardino G. Non-steroidal Anti-inflammatory Drugs (1985), Wiley and Sons, New York
13. Morreale P., Manopulo R., Galati M., Boccanera L., Saponati G., and Bocchi L. Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J. Rheumatol. 23 (1996) 1385-1391
14. Park E.S., Chang S.Y., Hahn M., and Chi S.C. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int. J. Pharm. 209 (2000) 109-119
15. Rovetta G., Monteforte P., Molfetta G., and Balestra V. A two-year study of chondroitin sulfate in erosive osteoarthritis of the hands: behavior of erosions, osteophytes, pain and hand dysfunction. Drugs Exp. Clin. Res. 30 (2004) 11-16
16. Rubinstein A., Nakar D., and Sintov A. Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content. Pharm. Res. 9 (1992) 276-280
17. Salyers A.A., and O'Brien M. Cellular location of enzymes involved in chondroition sulfate breakdown by Bacteroides thetaiotaomicron. J. Bateriol. 143 (1980) 772-780
18. Saylers A.A. Energy sources of major intestinal fermentative anaerobes. Am. J. Clin. Nutr. 32 (1979) 158-163
19. Tsai M.F., Chiang Y.L., Wang L.F., Huang G.W., and Wu P.C. Oral sustained delivery of diclofenac sodium using calcium chondroitin sulfate matrix. J. Biomater. Sci. Polym. Ed. 16 (2005) 1319-1331
20. Volpi N. The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment. Curr. Drug Targets Immune Endocr. Metabol. Disord. 4 (2004) 119-127
21. Wang L.F., Chiang H.N., and Wu P.C. Kinetics and hydrolysis mechanism of polymeric prodrugs containing ibuprofen, ketoprofen, and naproxen as pendent agents. J. Biomater. Sci. Polym. Ed. 13 (2002) 287-299
22. Winter C., Risley E., and Nuss G. Carrageenan-induced oedema in hind paw of rats as an assay for anti-inflammatory drug. Proc. Soc. Exp. Biol. Med. 111 (1962) 544-547
23. Yano H., Hirayama F., Kamada M., Arima H., and Uekama K. Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration. J. Control. Release 79 (2002) 103-112
24. Zou M., Okamoto H., Cheng G., Hao X., Sun J., Cui F., and Danjo K. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems. Eur. J. Pharm. Biopharm. 59 (2005) 155-160